Stockscreener 앱 받기
0.241
4.52%
-0.0114
전일 마감가:
$0.2524
열려 있는:
$0.2575
하루 거래량:
1.16M
Relative Volume:
1.07
시가총액:
$10.87M
수익:
-
순이익/손실:
$-47.73M
주가수익비율:
-0.0167
EPS:
-14.3996
순현금흐름:
$-13.18M
1주 성능:
-19.67%
1개월 성능:
-26.10%
6개월 성능:
-46.97%
1년 성능:
-74.06%
1일 변동 폭
$0.2221
$0.26
1주일 범위
$0.2221
$0.3187
52주 변동 폭
$0.2221
$1.37
Gt Biopharma Inc Stock (GTBP) Company Profile
명칭
Gt Biopharma Inc
전화
(800) 304-9888
주소
505 MONTGOMERY STREET, SAN FRANCISCO
Compare GTBP vs PSNYW, GOODO, SHMD, DWLD, QQQE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 0.2846 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
5.00 | 394.14M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.92 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
3.15 | 315.90M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.39 | 0 | 0 | 0 | 0 | 0.00 |
QQQE
Direxion NASDAQ-100 Equal Weigh
|
120.75 | 0 | 0 | 0 | 0 | 0.00 |
Gt Biopharma Inc Stock (GTBP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 개시 | ROTH MKM | Buy |
| 2021-05-24 | 개시 | H.C. Wainwright | Buy |
| 2021-04-13 | 개시 | B. Riley Securities | Buy |
| 2021-03-17 | 개시 | ROTH Capital | Buy |
Gt Biopharma Inc 주식(GTBP)의 최신 뉴스
GT Biopharma Inc (NASDAQ: GTBP) Share Price, GTBP Stock News, GTBP Share Price & Updates - Kalkine
Stock Quotes, Business News and Data from Stock Markets | MSN Money - MSN
GTBP Q1 2026 Earnings: EPS Misses Estimates as Stock Drops 3.72%Dividend Cut Risk - vinanet.vn
GT Biopharma Shareholders Approve Reverse Split and Incentive Plan - TipRanks
GT Biopharma (NASDAQ: GTBP) wins approval for reverse split and share plan changes - Stock Titan
GT Biopharma Q2 Results: Net Loss Falls To $4.5 Million - scanx.trade
Gt Biopharma Reports Second Quarter 2026 Financial Results - TradingView
GTBP: Q2 2026 net loss narrowed to $4.5M as clinical programs advance and cash runway extends to Q4 2026 - TradingView
GT Biopharma Reports Second Quarter 2026 Financial Results - The Manila Times
GT Biopharma (GTBP) cuts net loss but flags going concern and Nasdaq risk - Stock Titan
GTBP Q1 2026 Earnings: Wider Loss Misses Estimates as Clinical Investment ContinuesEarnings Stability Report - vinanet.vn
GT Biopharma Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
GT Biopharma Inc (GTBP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GT Biopharma Inc (GTBP) Stock News Today - TradingKey
GT Biopharma’s TriKE® Program: Pipeline, Progress, & What’s Ahead - SmallCap Asia
GTBP Q2'26 Earnings: revenue estimate is 0 USD - TradingView
GTBP Q1 2026 Earnings: Wider Loss Misses Estimates as Clinical-Stage Pipeline AdvancesEstimate Accuracy - Vinanet
GT Biopharma (GTBP) Slips 4.65% to $0.29, Testing Critical Support Near $0.28Trend Reversal Picks - dars.gov.et
GT BIOPHARMA INC (GTBP) Stock Chart - ChartMill
GTBP Q1 2026 Earnings: Wider-than-Expected Loss Amid Ongoing R&D InvestmentProfit Growth Outlook - vinanet.vn
GT Biopharma Edges Higher as Biotech Sector Sees Renewed Interest — GTBP Hovers Near Key LevelsSmart Beta Flow - po-news-eg.net
GT Biopharma Inc (GTBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GT Biopharma Inc (GTBP) Cash Flow - TradingKey
GT Biopharma Inc (GTBP) Income Statement - tradingkey.com
GTBP|GT Biopharma Inc|Price:0.335|Chg%:+0.011 - TradingKey
GT Biopharma Inc (GTBP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GTBP|GT Biopharma Inc|Price:0.310|Chg%:-0.011 - TradingKey
GT Biopharma Inc (GTBP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
GT Biopharma Inc (GTBP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GTBP|GT Biopharma Inc|Price:0.324|Chg%:-0.011 - TradingKey
GT Biopharma Shares Decline 3.25% as Stock Tests Key Support at $0.30Ichimoku Entry - dars.gov.et
GT Biopharma(GTBP) Stock Options Chain | Quotes & News - Moomoo
GT Biopharma, Inc. Revenue Breakdown – NASDAQ:GTBP - TradingView
GT Biopharma Inc (GTBP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Price to earnings forward of GT Biopharma, Inc. – NASDAQ:GTBP - TradingView
Price to earnings forward of GT Biopharma Inc – SWB:OXIA - TradingView
GT Biopharma (GTBP) Declines 3.96% as Stock Nears Critical $0.32 Support LevelVolume Weighted Price - vinanet.vn
Immunotherapy Breakthroughs Propel Clinical Momentum Ahead of ESMO Congress - Baystreet.ca
GTBP Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Ongoing Pre-Revenue StageTrough Earnings Signal - vinanet.vn
GT Biopharma (GTBP) Slides to $0.42 Amid Continued Selling PressureLast Point Resistance - po-news-eg.net
GT Biopharma (GTBP) Revenue BreakdownMain Composition - Moomoo
A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs - Newswire Canada
GTBP News | GT BIOPHARMA INC (NASDAQ:GTBP) - ChartMill
GT Biopharma (GTBP) plans reverse stock split and larger 2022 incentive plan - Stock Titan
Enterprise value to EBITDA forward of GT Biopharma, Inc. – NASDAQ:GTBP - TradingView
A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs - PR Newswire Canada
Enterprise value to EBITDA forward of GT Biopharma Inc – MUN:OXIA - TradingView
Enterprise value to revenue forward of GT Biopharma, Inc. – NASDAQ:GTBP - TradingView
Price to book forward of GT Biopharma Inc – FWB:OXIA - TradingView
Enterprise value to EBITDA forward of GT Biopharma Inc – FWB:OXIA - TradingView
Enterprise value to revenue forward of GT Biopharma Inc – FWB:OXIA - TradingView
Gt Biopharma Inc (GTBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):